InflaRx
Jacky Schmitt joined the InflaRx operations team as a freelance in January 2022. Previously, Jacky has already been working for the company on various CMC subjects during one year as an external consultant.
With more than 25 years experience in the areas of biopharmaceutical development and GMP manufacturing, Dr. Schmitt brings his valuable experience for the management of manufacturing operations at InflaRx.
Jacky Schmitt holds a Ph.D. in molecular biology, an engineer degree in biotechnology, as well as a master of business administration from University of Strasbourg in France.
This person is not in any teams
This person is not in any offices
InflaRx
InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a.